Presentation is loading. Please wait.

Presentation is loading. Please wait.

Swiss Life Sciences Trend Analysis 2017

Similar presentations


Presentation on theme: "Swiss Life Sciences Trend Analysis 2017"— Presentation transcript:

1 Swiss Life Sciences Trend Analysis 2017

2 About Us The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. The Swiss Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with Swiss Biotech Association, Biotechnet, BaselArea and Life Sciences Zurich. Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy.

3 Overview of the Swiss Life-science Industry
April 2017 Statistics Total Biotech Companies 430 Medtech companies 232 Pharma companies 70 Investor companies 44 Public / Non-Profit Organizations / Medical Facilities 211 Other life science related companies 1060 Percentage of Publicly Owned Companies 1.8% Biotech Venture financing 2015 / 2016 USD 409m / USD 370m Life Sciences Venture Financing 2015 / 2016 USD 782m / USD 458m Number of Technologies 201 Licensing Opportunities 92

4 Overview of the Swiss Biotechnology Industry
2017 Statistics Total Biotech companies 430 Biotech – Therapeutics and Diagnostics 144 Biotech – R&D Services 208 Biotech - Other 78 Percentage of SMEs 78% Percentage of publicly owned companies 2% Biotech venture financing 2015/2016 USD 409m / USD 370m Licensing opportunities 79

5 Number of Employees

6 Company Ownership Life Science Companies by Ownership Status
Biotechnology Companies by Ownership Status

7 Company Foundation Timeline

8 Key Activities of Biotechnology Companies

9 Biotech products - Breakdown by Indication

10 Products in the Pipeline

11 Biotechnology Financing in Switzerland – 5 year report

12 Major Biotech Venture Financing Rounds in 2016
Company Sector USD M ADC Therapeutics, Inc Biotech – Therapeutics & Diagnostics 105 Cardiorentis AG 60 AC Immune SA 44

13 About Biotechgate Biotechgate contains over 42,000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data. To register for a trial or to learn more about the different subscription options, please visit

14 Terms of Use The “Swiss Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof. The use of the figures and graphs provided in this report is free of charge for any presentations as long as is clearly cited as the source. For all other uses please contact us for terms and conditions. Biotechgate c/o Venture Valuation VV AG Kasernenstrasse 11 8004 Zurich Switzerland +41 (43)


Download ppt "Swiss Life Sciences Trend Analysis 2017"

Similar presentations


Ads by Google